John McKew

John McKew

President chez LUMOS PHARMA, INC.

Fortune : 47 342 $ au 30/04/2024

59 ans
Health Technology
Consumer Services
Government

Provenance du réseau au premier degré de John McKew

EntitéType d'entitéIndustrie
Public Company Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 10
9
Government General Government 9
Boston University School of Medicine
5
College/University Other Consumer Services 5
2
Subsidiary Medical/Nursing Services 2

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à John McKew via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Biotechnology

Srini Akkaraju Akkaraju

Joseph McCracken

Ashraf Amanullah

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

THERMOGENESIS HOLDINGS, INC. Medical Specialties

Mahendra S. Rao

Director/Board Member

CYMABAY THERAPEUTICS, INC. Biotechnology

Edward Penhoet

David Karpf

Chairman

Chief Tech/Sci/R&D Officer

Medical Specialties

Frédéric Chéreau

Mark Goldberg

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Biotechnology

Srini Akkaraju Akkaraju

Edward Penhoet

Emmett Cunningham

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Mahendra S. Rao

Founder

AMBIT BIOSCIENCES CORP Pharmaceuticals: Major

Carole Nüchterlein

Marcy Graham

Director/Board Member

Investor Relations Contact

Medical Specialties

Kevin Lalande

Thomas Raffin

Director/Board Member

Director/Board Member

LDR HOLDING CORP Medical Specialties

Kevin Lalande

Thomas Raffin

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mahendra S. Rao

Founder

Biotechnology

Charles Link

Carl W. Langren

Chairman

Director of Finance/CFO

GALERA THERAPEUTICS, INC. Pharmaceuticals: Major

Emmett Cunningham

Eugene Kennedy

Director/Board Member

Chief Tech/Sci/R&D Officer

College/University

Gary Nabel

Jennifer F. Tseng

Doctorate Degree

Graduate Degree

Stanford University College/University

Srini Akkaraju Akkaraju

Edward Penhoet

Thomas Raffin

Jennifer F. Tseng

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Gil Omenn

Edward Penhoet

Corporate Officer/Principal

Doctorate Degree

Biotechnology

Jon Saxe

Joseph McCracken

General Counsel

Corporate Officer/Principal

University of Utah College/University

Mahendra S. Rao

Corporate Officer/Principal

Iowa State University College/University

Chad Johnson

Bradley Powers

Graduate Degree

Graduate Degree

The Johns Hopkins University College/University

Emmett Cunningham

Mahendra S. Rao

Doctorate Degree

Corporate Officer/Principal

Texas Tech University College/University

Lota Zoth

Aaron Schuchart

Undergraduate Degree

Undergraduate Degree

College/University

Mahendra S. Rao

Doctorate Degree

New York University College/University

Emmett Cunningham

Martha Somerman

Corporate Officer/Principal

Undergraduate Degree

University of California, Berkeley College/University

Edward Penhoet

David Karpf

Corporate Officer/Principal

Undergraduate Degree

University of California San Diego College/University

David Karpf

Emmett Cunningham

David Weiner

Fred Ramsdell

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

University of Iowa College/University

Garry Neil

Carl W. Langren

Corporate Officer/Principal

Undergraduate Degree

University of Michigan College/University

Gil Omenn

Carole Nüchterlein

John Niederhuber

Chief Tech/Sci/R&D Officer

Graduate Degree

Corporate Officer/Principal

University of Mumbai College/University

Mahendra S. Rao

Undergraduate Degree

PLUS THERAPEUTICS, INC. Pharmaceuticals: Major

Richard Hawkins

An van Es-Johansson

Chairman

Director/Board Member

Miscellaneous Commercial Services

Nancy Andrews

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Gil Omenn

Edward Penhoet

Nancy Andrews

Corporate Officer/Principal

Corporate Officer/Principal

Chairman

Miscellaneous Commercial Services

Gil Omenn

Edward Penhoet

Nancy Andrews

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Drugstore Chains

Richard Hawkins

Robert J. Davis

Chief Executive Officer

Corporate Officer/Principal

Harvard Medical School College/University

Gil Omenn

Mark Goldberg

Nancy Andrews

Doctorate Degree

Doctorate Degree

Doctorate Degree

Miscellaneous Commercial Services

Mahendra S. Rao

Corporate Officer/Principal

Central Iowa Hospital Corp.

Charles Link

Founder

Stanford University School of Medicine College/University

David Karpf

Emmett Cunningham

Thomas Raffin

Charles Link

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Harvard College College/University

Mark Goldberg

Gary Nabel

Undergraduate Degree

Undergraduate Degree

Drake University Law School College/University

Chad Johnson

Bradley Powers

Graduate Degree

Graduate Degree

UCSF School of Medicine College/University

Emmett Cunningham

Jennifer F. Tseng

Corporate Officer/Principal

Doctorate Degree

Biotechnology

Yossef Av-Gay

Founder

SAVARA INC. Pharmaceuticals: Major

Richard Hawkins

Joseph McCracken

An van Es-Johansson

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Charles Link

Director/Board Member

Miscellaneous Commercial Services

Thomas Raffin

Charles Link

Director/Board Member

Director/Board Member

AADI BIOSCIENCE, INC. Biotechnology

Marcy Graham

Investor Relations Contact

Statistiques

Internationale

Etats-Unis 47
Inde 3
Belgique 2
Israël 2

Sectorielle

Health Technology 22
Consumer Services 20
Commercial Services 8
Electronic Technology 2
Retail Trade 2

Opérationnelle

Director/Board Member 305
Corporate Officer/Principal 150
Independent Dir/Board Member 90
Chairman 50
Chief Tech/Sci/R&D Officer 48
  1. Bourse
  2. Insiders
  3. John McKew
  4. Connexions Sociétés
-40% Prolongation exceptionnelle : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT